Template Agreement between a patient or patient advocacy organization and a pharmaceutical companyTemplate Agreement • April 9th, 2021
Contract Type FiledApril 9th, 2021For the purpose of this document, we use the term “Patient Consultant” in a broader sense for individual patients, caregivers, and patient organization representatives. You can find the definitions in the NHC Fair-Market Value Calculator Glossary of Terms. People, organizations, or companies that should compensate patients for engagement activities include biopharmaceutical, device, and diagnostic companies; academic researchers; patient-advocacy groups; policy makers; health care systems; and others who seek to engage patients as partners. Throughout this document, they are referred to as the “Company”.